Middle cerebral artery stenting for acute ischemic stroke after unsuccessful Merci retrieval

Neurosurgery

Volumn 60, Issue 4, 2007, Pages 701-706

  Sauvageau, Eric ^a,c   Samuelson, Rodney M ^b,c   Levy, Elad I ^a,c   Jeziorski, Alison M ^b,c   Mehta, Ricky A ^b,c   Hopkins, L Nelson ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Toshiba Stroke Research Center   (United States)

Author keywords

Acute ischemic stroke; Intracranial stenting; Merci retriever; Middle cerebral artery

Indexed keywords

EPTIFIBATIDE; RETEPLASE;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMATOMA; CEREBROVASCULAR ACCIDENT; DATA BASE; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERFORATION; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; STENT; SUBARACHNOID HEMORRHAGE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EMBOLECTOMY; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; STENTS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34147204082     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000255419.01302.66     Document Type: Article

References (24)

1. Abou-Chebl A, Bajzer CT, Krieger DW, Furlan AJ, Yadav JS: Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke 36:2286-2288, 2005.
2. Anonymous: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 336:1689-1696, 1997.
3. Anonymous: Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study. Lancet 349:1429-1435, 1997.
4. Anonymous: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 330:956-961, 1994.
5. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: Acomparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:142-154, 1987.
6. Choi JH, Bateman BT, Mangla S, Marshall RS, Prabhakaran S, Chong J, Mohr JP, Mast H, Pile-Spellman J: Endovascular recanalization therapy in acute ischemic stroke. Stroke 37:419-424, 2006.
7. ESPRIT Investigators. Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy: Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): Arandomised, placebo-controlled trial. Lancet 356:2037-2044, 2000.
8. Food and Drug Administration, Department of Health and Human Services: Concentric Merci Retriever. http://www.fda.gov/cdrh/pdf3/k033736.pdf. Accessed August 8, 2006.
9. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011, 1999.
10. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, Pile-Spellman J, Segal A, Viñuela F, Saver JL: MERCI 1: A phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 35:2848-2854, 2004.
11. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC: Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341:1949-1956, 1999.
12. Levy EI, Ecker RD, Hanel RA, Sauvageau E, Wehman JC, Guterman LR, Hopkins LN: Acute M2 bifurcation stenting for cerebral infarction: Lessons learned from the heart: Technical case report. Neurosurgery 58:E588, 2006.
13. Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, Jovin TG, Guterman LR, Hopkins LN: Stent-assisted intracranial recanalization for acute stroke: Early results. Neurosurgery 58:458-463, 2006.
14. Qureshi AI, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani JF, Suri MF, Boulos AS, Hopkins LN: Reocclusion of recanalized arteries during intraarterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 25:322-328, 2004.
15. Qureshi AI, Siddiqui AM, Suri MF, Kim SH, Ali Z, Yahia AM, Lopes DK, Boulos AS, Ringer AJ, Saad M, Guterman LR, Hopkins LN: Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study. Neurosurgery 51:1319-1329, 2002.
16. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26:14-20, 1995.
17. Sauvageau E, Levy EI: Self-expanding stent-assisted middle cerebral artery recanalization: Technical note. Neuroradiology 48:405-408, 2006.
18. Smith WS: Results of the Multi-MERCI trial (abstract P503). Stroke 37:711-712, 2006.
19. Smith WS: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 27:1177-1182, 2006.
20. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP; MERCI Trial Investigators: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 36:1432-1440, 2005.
21. Steinhubl SR, Talley JD, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, Navetta FI, Berger PB, Popma JJ, Dangas G, Gallo R, Sane DC, Saucedo JF, Jia G, Lincoff AM, Theroux P, Holmes DR, Teirstein PS, Kereiakes DJ: Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: Results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 103:2572-2578, 2001.
22. Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM: Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350:1217-1219, 1997.
23. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27:1974-1980, 1996.
24. Zaidat OO, Suarez JI, Sunshine JL, Tarr RW, Alexander MJ, Smith TP, Enterline DS, Selman WRR, Landis DM: Thrombolytic therapy of acute ischemic stroke: Correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 26:880-884, 2005.